Asia

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

See Prices or Subscribe
Asia

Latest Asia Analysis

Industry Trend Analysis - Shift Away From Austerity To Benefit Drugmakers - JULY 2015

Pharmaceutical companies will benefit from Australia's FY2015/16 budget. Critically, the budget has moved away from its focus on austerity due to the political resistance in shifting medical costs onto consumers - boding well for healthcare access. In addition, commercial opportunities will be augmented following the government's allocation of AUD1.6bn (USD1.2bn) towards expanding the number of...

READ FULL ARTICLE...